1. Home
  2. ECOR vs VTSI Comparison

ECOR vs VTSI Comparison

Compare ECOR & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • VTSI
  • Stock Information
  • Founded
  • ECOR 2005
  • VTSI 1993
  • Country
  • ECOR United States
  • VTSI United States
  • Employees
  • ECOR N/A
  • VTSI N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • ECOR Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • ECOR Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • ECOR 40.1M
  • VTSI 45.2M
  • IPO Year
  • ECOR 2018
  • VTSI N/A
  • Fundamental
  • Price
  • ECOR $5.19
  • VTSI $4.60
  • Analyst Decision
  • ECOR Strong Buy
  • VTSI Strong Buy
  • Analyst Count
  • ECOR 2
  • VTSI 2
  • Target Price
  • ECOR $25.50
  • VTSI $13.00
  • AVG Volume (30 Days)
  • ECOR 122.7K
  • VTSI 67.1K
  • Earning Date
  • ECOR 05-07-2025
  • VTSI 05-12-2025
  • Dividend Yield
  • ECOR N/A
  • VTSI N/A
  • EPS Growth
  • ECOR N/A
  • VTSI N/A
  • EPS
  • ECOR N/A
  • VTSI 0.12
  • Revenue
  • ECOR $25,182,000.00
  • VTSI $26,350,819.00
  • Revenue This Year
  • ECOR $32.20
  • VTSI N/A
  • Revenue Next Year
  • ECOR $46.27
  • VTSI $22.35
  • P/E Ratio
  • ECOR N/A
  • VTSI $37.08
  • Revenue Growth
  • ECOR 57.09
  • VTSI N/A
  • 52 Week Low
  • ECOR $5.02
  • VTSI $3.57
  • 52 Week High
  • ECOR $19.49
  • VTSI $17.68
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 31.29
  • VTSI 54.70
  • Support Level
  • ECOR $6.01
  • VTSI $4.23
  • Resistance Level
  • ECOR $7.14
  • VTSI $4.61
  • Average True Range (ATR)
  • ECOR 0.80
  • VTSI 0.32
  • MACD
  • ECOR 0.07
  • VTSI 0.10
  • Stochastic Oscillator
  • ECOR 3.99
  • VTSI 77.44

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: